Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.370, 2002-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Isoniazid programme to prevent TB cost effective in the US
Inpharma, Vol. 1, Iss. 1345, 2002-01 ,pp. :
Access to resources
Recommend
Isoniazid cost study applauded, US recommendations updated
Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. :
Isoniazid cost saving vs rifampicin/pyrazinamide in latent TB
Inpharma, Vol. 1, Iss. 1427, 2004-01 ,pp. :
Isoniazid cost saving vs rifampicin/pyrazinamide in latent TB
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 447, 2004-01 ,pp. :
TB screening cost effective in two different settings
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 657, 2012-01 ,pp. :